SDK to Enter Purification Resin Market through Strategic Investment
News Dec 10, 2012
Showa Denko K.K. (SDK) has signed a strategic partnership agreement with BIA Separations (BIASep), of Austria.
The partnership includes SDK’s investment in BIASep as well as joint marketing and R&D.
With the partnership, SDK will be ready to expand its business to a market of purification resins used for manufacturing biopharmaceuticals and for industrial applications.
SDK is conducting a separation/refining business, developing, manufacturing, and selling various products pertaining to high-performance liquid chromatography (HPLC).
SDK has been providing a wide variety of analytical HPLC columns with the brand name of “Shodex™” for more than 40 years.
The Shodex™ columns are delivered to wide-ranging customers in the world, including public institutions and R&D/quality control sectors of private enterprises, through the Showa Denko Group’s global sales network.
This time, SDK decided to enter the purification resin market through the strategic partnership with BIASep, expecting to achieve good synergistic effect in terms of both technology and product mix.
The market is expected to grow rapidly with the expansion of the biopharmaceutical industry. SDK will fully utilize the technologies it has amassed through the Shodex™ business to enhance the synergies.
Purification resins are used for refining desired components/chemicals from culture/reaction solutions for biopharmaceutical and industrial manufacturing processes.
SDK’s protein analysis technology and know-how acquired through the Shodex™ business will be fully utilized, as protein purification plays a key role in the purifying process for biopharmaceuticals.
Efficiency in purification is generally low, resulting in high production costs of biopharmaceuticals. However, BIASep has developed CIM® Monoliths (CIM Convective Interaction Media®), which ensure more efficient purification, compared with competitors’ purification resins.
SDK has judged that it is best to enter into a tie-up with BIASep to realize a participation in the purification resin market.
Through the partnership arrangement with BIASep, SDK will acquire know-how concerning development, production, quality control, and marketing of purification resins.
Furthermore, SDK will aim to strengthen business relations with producers of biopharmaceuticals, thereby expanding its separation/refining business.
Changes Identified in Body Cells During Type2 Diabetes OnsetNews
Researchers have found fresh evidence to explain the processes that occur in the body’s cells leading to the onset of type2 diabetes. Utilising metabolomics, results showed that amino acids play a contributory role in the onset of type2 diabetes in some younger and older patients, as the metabolism of specific amino acids is adversely affected.
Honey Bee Gut Metabolome Reveals How They Cope With a Pollen Rich DietNews
The honey bee gut is colonized by specialized bacteria that help digest components of the floral pollen diet and produce molecules that likely promote bee health. Researchers studied the metabolome from the bee gut and have uncovered which bacterial species perform which specific digestive functions.
Novel Isotope Tracking Method Offers Hope for Threatened SpeciesNews
Locating even a single nest of the secretive goshawk required weeks of exploration. So scientists decided to conduct elemental analysis using strontium, which has naturally occurring isotopes found everywhere on Earth that travel the food chain from the soil to plants to herbivores and predators. Analysing prey remains enabled the researchers to determine where the birds of prey were hunting, findings that could help steer conservation efforts for goshawks and other vulnerable species.READ MORE